HSPA9 and female reproductive organ cancer: In contrast, another research group revealed higher mortalin expression versus normal controls in 16/24 tumor tissues including bladder, brain, breast, colon, duodenum, fallopian tube, gallbladder, kidney, liver, pancreas, parotid, prostate, thymus, thyroid, ureter, and uterus neoplasms, and no significant change in mortalin level in 8/24 tumor tissues (including ovary, adrenal gland, lung, esophagus, rectum, stomach, testis, and lymphoma) [13].